John D. Cleary

Also affiliated with University of Florida, University at Albany, State University of New York, University of Arts

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Drug Screen Tugs at Common Thread for Repeat Disorders”.

Drug Screen Tugs at Common Thread for Repeat Disorders

Trends in Pharmacological Sciences(2020)10.1016/j.tips.2019.12.004

N/A

0DataRank · unranked

3 citations

John D. Cleary, J. Andrew Berglund, Kaalak Reddy

The alternative initiation factor eIF2A plays key role in RAN translation of myotonic dystrophy type 2 CCUG•CAGG repeats

Human Molecular Genetics(2021)10.1093/hmg/ddab098

N/A

0DataRank · unranked

31 citations

Lien Nguyen, Kiruphagaran Thangaraju, Jian Jian Li, John D. Cleary, Tao Zu +2 more

Therapeutic strategies for C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia

Current Opinion in Neurology(2021)10.1097/wco.0000000000000984

N/A

0DataRank · unranked

21 citations

John D. Cleary, Shu Guo, Laura P.W. Ranum, Guillaume M. Hautbergue

Molecular characterization of myotonic dystrophy fibroblast cell lines for use in small molecule screening

iScience(2022)10.1016/j.isci.2022.104198

N/A

0DataRank · unranked

18 citations

Alana O’Brien, Kiril Poukalov, Yidan Lu, Jesús Frías, Hannah K. Shorrock +10 more

Widespread alternative splicing dysregulation occurs presymptomatically in CAG expansion spinocerebellar ataxias

Brain(2023)10.1093/brain/awad329

N/A

0DataRank · unranked

14 citations

Claudia D. Lennon, Asmer Aliyeva, Emily E Davey, Cristina C. DeMeo, Caroline E. Pritchard +7 more

Individual transcriptomic response to strength training for patients with myotonic dystrophy type 1

JCI Insight(2023)10.1172/jci.insight.163856

N/A

0DataRank · unranked

14 citations

Cécilia Légaré, Lori Planco, Sharon Shaughnessy, Claudia D. Lennon, Marie‐Pier Roussel +6 more

Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.02.526846

N/A

0DataRank · unranked

7 citations

Sawyer M Hicks, Jesús Frías, Sweta Vangaveti, Masayuki Nakamori, John D. Cleary +3 more

Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102338

N/A

0DataRank · unranked

9 citations

Jesús Frías, Subodh Kumar Mishra, Marina M. Scotti, Derek R. Muscato, M. Carmen Valero +6 more

Dysregulation of alternative splicing is a transcriptomic feature of patient-derived fibroblasts from CAG repeat expansion spinocerebellar ataxias

Human Molecular Genetics(2024)10.1093/hmg/ddae174

N/A

0DataRank · unranked

3 citations

Claudia D. Lennon, John D. Cleary, Hannah K. Shorrock, J. Andrew Berglund, Asmer Aliyeva

Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1

Human Molecular Genetics(2024)10.1093/hmg/ddae125

N/A

0DataRank · unranked

3 citations

Jesús Frías, Jacob H Schroader, Lindsey A. Jones, Emily E Davey, Claudia D. Lennon +5 more